BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31443309)

  • 1. Malignant Pleural Effusion and Its Current Management: A Review.
    Skok K; Hladnik G; Grm A; Crnjac A
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
    Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
    Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
    Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
    Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
    Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
    Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERS/EACTS statement on the management of malignant pleural effusions.
    Bibby AC; Dorn P; Psallidas I; Porcel JM; Janssen J; Froudarakis M; Subotic D; Astoul P; Licht P; Schmid R; Scherpereel A; Rahman NM; Maskell NA; Cardillo G
    Eur J Cardiothorac Surg; 2019 Jan; 55(1):116-132. PubMed ID: 30060030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
    Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
    Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural Effusion in Multiple Myeloma.
    Wang Z; Xia G; Lan L; Liu F; Wang Y; Liu B; Ding Y; Dai L; Zhang Y
    Intern Med; 2016; 55(4):339-45. PubMed ID: 26875957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural effusion: tumor-host interactions unleashed.
    Stathopoulos GT; Kalomenidis I
    Am J Respir Crit Care Med; 2012 Sep; 186(6):487-92. PubMed ID: 22652027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa.
    Koegelenberg CFN; Bennji SM; Boer E; Schubert PT; Shaw JA; Allwood BW; Irusen EM
    S Afr Med J; 2018 Mar; 108(4):275-277. PubMed ID: 29629675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
    Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
    Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant Pleural Effusion: Still a Long Way to Go.
    Meriggi F
    Rev Recent Clin Trials; 2019; 14(1):24-30. PubMed ID: 30514193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
    Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
    Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
    Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
    Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the diagnosis and management of malignant pleural effusions.
    Heffner JE; Klein JS
    Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.
    Tsai TH; Wu SG; Hsieh MS; Yu CJ; Yang JC; Shih JY
    Lung Cancer; 2015 May; 88(2):208-14. PubMed ID: 25773866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer.
    Nasser S; Fotopoulou C; Richter R; Kaulich J; Braicu E; Beteta C; Olschewski J; Babayeva A; Sehouli J
    Anticancer Res; 2021 Apr; 41(4):2033-2038. PubMed ID: 33813410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
    Porcel JM; Solé C; Salud A; Bielsa S
    Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.